NCT03415516

Brief Summary

The aim of this randomized, controlled, prospective clinical trial is to evaluate the performances of two different universal adhesives and an etch\&rinse adhesive in restoration of non-caries cervical lesions. Twenty patients will receive restorations. Lesions will be divided into 7 groups according to adhesive systems and application modes: GSE: Gluma Universal- self etch, GSL: Gluma Universal-selective etching, GER: Gluma Universal-etch\&rinse, ASE: All Bond Universal- self etch, ASL: All Bond Universal- selective etching, AER: All Bond Universal- etch\&rinse, SB (Control): Single Bond2+etch\&rinse. Restorations (nano-hybrid composite) will be scored with regard to retention, marginal discoloration, marginal adaptation, recurrent caries and post operative sensitivity using modified USPHS criteria after 48 months. Two examiners who is not involved in the placement of restorations will conduct the evaluations. Descriptive statistics will be performed using Chi-square tests.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2015

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

December 23, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 30, 2018

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
Last Updated

September 14, 2021

Status Verified

September 1, 2021

Enrollment Period

4 months

First QC Date

December 23, 2017

Last Update Submit

September 13, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical performances of different adhesives

    Two year examinations according to USPHS criteria

    Two years

Study Arms (7)

Gluma Universal, self-etch mode (GSE)

EXPERIMENTAL
Device: Gluma Universal

Gluma Universal, selective etching (GSL)

EXPERIMENTAL
Device: Gluma Universal

Gluma Universal, etch&rinse (GER)

EXPERIMENTAL
Device: Gluma Universal

All Bond Universal, self-etch (ASE)

EXPERIMENTAL
Device: All Bond Universal

All Bond Universal, selective etching (ASL)

EXPERIMENTAL
Device: All Bond Universal

All Bond Universal, etch&rinse (AER)

EXPERIMENTAL
Device: All Bond Universal

Single Bond2, etch&rinse (SBU)

EXPERIMENTAL
Drug: Single Bond2

Interventions

Adhesive systems

Gluma Universal, etch&rinse (GER)Gluma Universal, selective etching (GSL)Gluma Universal, self-etch mode (GSE)

Adhesive systems

All Bond Universal, etch&rinse (AER)All Bond Universal, selective etching (ASL)All Bond Universal, self-etch (ASE)

Adhesive systems

Single Bond2, etch&rinse (SBU)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • being 18 years or older,
  • having no medical or behavioral problems preventing then from attending review visits,
  • having at least 7 tooth with NCCLs (d) having antagonist teeth.

You may not qualify if:

  • Exlusion criteria will be:
  • poor gingival health,
  • uncontrolled, rampant caries,
  • bruxism,
  • removable partial dentures,
  • xerostomia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Tooth Wear

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 23, 2017

First Posted

January 30, 2018

Study Start

July 1, 2015

Primary Completion

November 1, 2015

Study Completion

November 1, 2018

Last Updated

September 14, 2021

Record last verified: 2021-09